Can Pfizer Challenge Lilly and Novo Nordisk in the Obesity Market?
Weight loss translates into profits for investors. Just look at Eli Lilly And Novo Nordisk. Both stocks have risen dramatically thanks in large part to their obesity drugs, with Lilly's stock more than quadrupling and Novo's…